CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer

NCT05143151 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Carcinoma

Interventions

BIOLOGICAL: CD276 CAR-T cells

Sponsor

Shenzhen University General Hospital